Status:
RECRUITING
Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Sentinel Lymph Node
Head and Neck Squamous Cell Carcinoma
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Head and neck squamous cell carcinoma is the sixth most common malignant tumor in the world. Cervical lymph node metastasis is frequently encounted on the date of diagnosis. Surgical resection is one ...
Eligibility Criteria
Inclusion
- Aged 18-70;
- Pathological biopsy indicated head and neck squamous cell carcinoma;
- MR/CT examination indicate no suspected cervical lymph node metastasis;
- The patient intent to perform primary focal resection and unilateral/bilateral neck dissection at our center;
- agree to participate in clinical trials and sign informed consent.
Exclusion
- allergic to microbubbles contrast agents;
- patients who cannot tolerate surgery;
- enlarged cervical lymph node in palpation or suspected cervical lymph node metastasis indicated in MR/CT examination;
- distant metastasis.
Key Trial Info
Start Date :
September 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 28 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05437380
Start Date
September 20 2022
End Date
June 28 2026
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-sen Memorial Hospital
Guangzhou, Guangdong, China, 510000